Annual ROE
-51.92%
+16.12%+23.69%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual return on equity is -51.92%, with the most recent change of +16.12% (+23.69%) on December 31, 2023.
- During the last 3 years, PRQR annual ROE has risen by +23.81% (+31.44%).
- PRQR annual ROE is now -101.48% below its all-time high of 3515.30%, reached on December 31, 2013.
Performance
PRQR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-66.59%
-14.40%-27.59%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly return on equity is -66.59%, with the most recent change of -14.40% (-27.59%) on September 1, 2024.
- Over the past year, PRQR quarterly ROE has dropped by -3.88% (-6.19%).
- PRQR quarterly ROE is now -101.36% below its all-time high of 4893.90%, reached on March 31, 2014.
Performance
PRQR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PRQR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.7% | -6.2% |
| 3 y3 years | +31.4% | +2.0% |
| 5 y5 years | -26.7% | +2.0% |
PRQR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.6% | -27.6% | +16.9% |
| 5 y | 5-year | at high | +31.4% | -27.6% | +16.9% |
| alltime | all time | -101.5% | +50.4% | -101.4% | +47.9% |
ProQR Therapeutics NV ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -66.59%(+27.6%) |
| Jun 2024 | - | -52.19%(-9.6%) |
| Mar 2024 | - | -57.76%(+8.7%) |
| Dec 2023 | -51.92%(-23.7%) | -53.15%(-15.2%) |
| Sep 2023 | - | -62.71%(-21.7%) |
| Jun 2023 | - | -80.11%(+5.0%) |
| Mar 2023 | - | -76.28%(+5.3%) |
| Dec 2022 | -68.04%(-6.4%) | -72.46%(+6.7%) |
| Sep 2022 | - | -67.93%(+23.7%) |
| Jun 2022 | - | -54.90%(-11.1%) |
| Mar 2022 | - | -61.75%(+2.6%) |
| Dec 2021 | -72.68%(-4.0%) | -60.17%(-7.0%) |
| Sep 2021 | - | -64.72%(-13.4%) |
| Jun 2021 | - | -74.75%(+9.9%) |
| Mar 2021 | - | -68.04%(+5.5%) |
| Dec 2020 | -75.73%(+26.6%) | -64.52%(+1.6%) |
| Sep 2020 | - | -63.48%(-0.8%) |
| Jun 2020 | - | -64.02%(-15.6%) |
| Mar 2020 | - | -75.87%(+2.8%) |
| Dec 2019 | -59.84% | -73.78%(+10.3%) |
| Sep 2019 | - | -66.91%(+30.6%) |
| Jun 2019 | - | -51.24%(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -54.24%(-10.2%) |
| Dec 2018 | -40.99%(-60.8%) | -60.39%(-17.7%) |
| Sep 2018 | - | -73.40%(-42.6%) |
| Jun 2018 | - | -127.80%(+2.5%) |
| Mar 2018 | - | -124.74%(+11.8%) |
| Dec 2017 | -104.65%(+35.8%) | -111.59%(+13.8%) |
| Sep 2017 | - | -98.09%(+19.1%) |
| Jun 2017 | - | -82.36%(+20.4%) |
| Mar 2017 | - | -68.39%(+16.4%) |
| Dec 2016 | -77.04%(+227.1%) | -58.76%(+22.2%) |
| Sep 2016 | - | -48.10%(+24.7%) |
| Jun 2016 | - | -38.58%(+14.8%) |
| Mar 2016 | - | -33.61%(+60.4%) |
| Dec 2015 | -23.55%(+94.3%) | -20.95%(+31.8%) |
| Sep 2015 | - | -15.90%(+23.8%) |
| Jun 2015 | - | -12.84%(+5.9%) |
| Mar 2015 | - | -12.13%(-20.1%) |
| Dec 2014 | -12.12%(-100.3%) | -15.18%(-40.4%) |
| Sep 2014 | - | -25.46%(-53.2%) |
| Jun 2014 | - | -54.40%(-101.1%) |
| Mar 2014 | - | 4893.90%(+77.7%) |
| Dec 2013 | 3515.30% | 2754.68% |
FAQ
- What is ProQR Therapeutics NV annual return on equity?
- What is the all time high annual ROE for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual ROE year-on-year change?
- What is ProQR Therapeutics NV quarterly return on equity?
- What is the all time high quarterly ROE for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly ROE year-on-year change?
What is ProQR Therapeutics NV annual return on equity?
The current annual ROE of PRQR is -51.92%
What is the all time high annual ROE for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual return on equity is 3515.30%
What is ProQR Therapeutics NV annual ROE year-on-year change?
Over the past year, PRQR annual return on equity has changed by +16.12% (+23.69%)
What is ProQR Therapeutics NV quarterly return on equity?
The current quarterly ROE of PRQR is -66.59%
What is the all time high quarterly ROE for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly return on equity is 4893.90%
What is ProQR Therapeutics NV quarterly ROE year-on-year change?
Over the past year, PRQR quarterly return on equity has changed by -3.88% (-6.19%)